IMAgINATION

SOUTH SAN FRANCISCO, Calif. — September 22, 2026 Genentech reported positive prespecified interim results from the ongoing Phase 3...

BASEL, Switzerland — September 23, 2026 Roche announced positive prespecified interim results from the ongoing Phase 3 IMAgINATION study...